Skip to main content
. 2023 Feb 12;13(2):440–449. doi: 10.3390/ejihpe13020033

Table 1.

General characteristics of the participants by study arms.

Control Intervention Total p
Female Sex 16 (84.2%) 10 (52.6%) 26 (68.4%) 0.079
Age (years) 68.7 ± 11.5 67.5 ± 10.3 68.1 ± 10.8 0.744
BMI (kg/m2) 29.4 ± 3.4 29.5 ± 4.6 29.5 ± 4.0 0.988
Born in Lima 5 (26.3%) 9 (47.4%) 14 (36.8%) 0.313
Marital status
Single 3 (15.8%) 2 (10.5%) 5 (13.2%) 0.026
Married/Cohabiting 7 (36.8%) 15 (79.0%) 22 (57.9%)
Divorced 1 (5.3%) 0 1 (2.6%)
Widow/widower 8 (42.1%) 2 (10.5%) 10 (26.3%)
Education level
Primary 13 (68.4%) 11 (57.9%) 24 (63.2%) 0.788
High school 5 (26.3%) 6 (31.6%) 11 (29.0%)
Superior 1 (3.3%) 2 (10.5%) 3 (7.9%)
Occupation
Housewife 11 (57.9%) 9 (47.4%) 20 (52.6%) 0.455
Casual work 2 (10.5%) 5 (26.3%) 7 (18.4%)
Permanent job 6 (31.6%) 5 (26.3%) 11 (29.0%)
HTA diagnosis time (months) 10 (5–12) 10 (3–16) 10 (5–15) 0.918
Treatment
ACEI 15 (79.0%) 9 (47.4%) 24 (63.2%) 0.248
ARA-II 3 (15.8%) 5 (26.3%) 8 (21.1%)
CCB 0 1 (5.3%) 1 (2.6%)
ARA-II + CCB 1 (5.3%) 3 (15.8%) 4 (10.5%)
ACEI + CCB + ARA-II 0 1 (5.3%) 1 (2.6%)
Family history of high blood pressure 10 (52.6%) 11 (57.9%) 21 (55.3%) 1
Comorbidities
Diabetes 6 (31.6%) 3 (15.8%) 9 (23.7%) 0.447
Others 14 (73.7%) 12 (63.2%) 26 (68.4%) 0.728

HTA: Arterial hypertension, ACEI: Angiotensin-converting enzyme inhibitors, ARA-II: angiotensin II receptor antagonists, CCB: calcium channel blockers.